Emergent BioSolutions (EBS) Tops Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.00 -3.38%
Revenue Growth %: -45.6%
Financial Fact:
Interest income: 358K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -45.6%
Financial Fact:
Interest income: 358K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q3 EPS of $2.19, $0.07 better than the analyst estimate of $2.12. Revenue for the quarter came in at $385.2 million versus the consensus estimate of $437.93 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Chime to acquire Stride Bank for $590M in cash
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
